Daniel Wainstein
Vorsitzender bei STELLA DIAGNOSTICS INC.
Vermögen: 555 $ am 31.05.2024
Aktive Positionen von Daniel Wainstein
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STELLA DIAGNOSTICS INC. | Vorsitzender | - | - |
CHAIN BRIDGE I | Vorsitzender | 01.01.2024 | - |
Seven Knots LLC | Corporate Officer/Principal | - | - |
Karriereverlauf von Daniel Wainstein
Ehemalige bekannte Positionen von Daniel Wainstein
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Direktor/Vorstandsmitglied | - | - |
JMD Properties, Inc.
JMD Properties, Inc. Medical SpecialtiesHealth Technology JMD Properties, Inc. is a content conversion service provider, developer, and integrator for the 3D Stereo and auto-stereo media industry. Its services include proprietary 3D reality splitter 2D to 3D conversion; stereo and multi-view consulting and integration; value added reseller of turnkey multi-view systems for digital signage. The company was founded in 1989 and is headquartered in Cheyenne, WY. | Vorstandsvorsitzender | - | - |
Ausbildung von Daniel Wainstein
Hofstra University | Undergraduate Degree |
Maurice A. Deane School of Law at Hofstra University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
2 |
Operativ
Chairman | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
STELLA DIAGNOSTICS INC. | Health Technology |
CHAIN BRIDGE I | Finance |
Private Unternehmen | 3 |
---|---|
JMD Properties, Inc.
JMD Properties, Inc. Medical SpecialtiesHealth Technology JMD Properties, Inc. is a content conversion service provider, developer, and integrator for the 3D Stereo and auto-stereo media industry. Its services include proprietary 3D reality splitter 2D to 3D conversion; stereo and multi-view consulting and integration; value added reseller of turnkey multi-view systems for digital signage. The company was founded in 1989 and is headquartered in Cheyenne, WY. | Health Technology |
Seven Knots LLC | |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Health Technology |
- Börse
- Insiders
- Daniel Wainstein
- Erfahrung